Alfredo Addeo, MD
Oncology Department, Geneva University Hospital, Geneva, Switzerland

Paolo A. Ascierto, MD
Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Instituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Naples, Italy

Joaquim Bellmunt, MD
Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Anders Bjartell, MD
Department of Urology, Skåne University Hospital, Malmö, Sweden

Hossein Borghaei, MD
Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

Fatima Cardoso, MD
Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal

Simon Chowdhury, MD
Consultant Medical Oncologist, London, UK

Eva M. Ciruelos, MD
Medical Oncology Department, Breast Cancer Unit, Hospital Universitario 12 de Octubre, Madrid, Spain

Javier Cortes, MD
Breast Cancer Research Program
Vall d’Hebron Institute of Oncology, Barcelona, Spain

Carmen Criscitiello, MD
Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy

Giuseppe Curigliano, MD
Division of Early Drug Development, European Institute of Oncology, Milan, Italy

Rebecca Dent, MD
Division of Medical Oncology, National Cancer Center Singapore, Singapore

Véronique Diéras, MD
Department of Medical Oncology, Centre Eugène Marquis, Rennes, France

Reinhard Dummer, MD
Department of Dermatology, University of Zurich, Switzerland

Ignacio Duran, MD
Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

Eleni Efstathiou, MD
University of Texas MD Anderson Cancer Center, Houston, TX, USA

Hermann Einsele, MD
Medizinische Klinik und Poliklinik II, ZIM, Universitätsklinikum Würzburg, Würzburg, Germany

Tarik Esen, MD
School of Medicine, Koç University, Istanbul, Turkey

Toby Eyre, MD
Oxford University Hospitals NHS Trust, Oxford, UK

Peter A. Fasching, MD
Department of Gynecology and Obstetrics Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany

Simone Ferrero, MD
Department of Molecular Biotechnology and Health Sciences, Turin, Italy

Karen Gelmon, MD
Department of Medical Oncology, BC Cancer Agency Vancouver, Vancouver, British Columbia, Canada

Alessandra Gennari, MD
Department of Translational Medicine, University of Piemonte Orientale;
Division of Oncology, Maggiore della Carita Hospital, Novara, Italy

Nicolas Girard, MD
Institut du Thorax Curie Montsouris, Institut Curie, Paris, France

Peter Goebell, MD
Department of Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany

Frank Griesinger, MD
Department of Hemtology and Oncology, Pius Hospital Oldenburg, Germany

Marc-Oliver Grimm, MD
Department of Urology, University Hospital Jena, Germany

Petros Grivas, MD
Division of Medical Oncology
University of Washington School of Medicine, Seattle, Washington, USA

Christian Grohé, MD
Internal medicine, cardiology and pulmonology, Evangelical Lung Clinic, Johannesstift Diakonie, Berlin, Germany

Hans Hammers, MD
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medcial Center, Dallas, Texas, USA

Nadia Harbeck, MD
Breast Center, Department of Obstetrics and Gynecology and CCCLMU, University of Munich, Germany

Axel Hauschild, MD
Department of Dermatology, Venerology and Allergology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany

Matthew D. Hellmann, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Lizza Hendriks, MD
Dept. of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands

Philipp Ivanyi, MD
Medizinische Hochschule Hannover, Germany

Wolfgang Janni, MD
Universitätsklinikum Ulm, Ulm, Germany

Mats Jerkeman, MD
Department of Hematology, Lund University Hospital, Lund, Sweden

Stephen R D Johnston, MD
The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK

Laura-Maria Krabbe, MD
Department of Urology, University of Münster, Münster, Germany

Marco Ladetto, MD
Hematology Division, Az Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

C. Ola Landgren, MD
Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami Health System, Miami, FL, US

Brea Lipe, MD
University of Rochester Medical Center, Rochester, NY, USA

Stephen Liu, MD
Thoracic Mecial Oncology and Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington D.C., USA

Georgina Long, MD
Melanoma Institute Australia, The University of Sydney, Sydney, Australia;
Royal North Shore Hospital, St Leonards, NSW, Australia

Yohann Loriot, MD
Department of Medical Oncology, Gustave Roussy, Villejuif, France

Diana Lüftner, MD
Immanuelklinik Märkische Schweiz, Buckow, Germany

Ana Marín Niebla, MD
Department of Hematology, Lymphoma Unit, University Hospital Vall d'Hebron, Barcelona, Spain

Axel S. Merseburger, MD
Department of Urology, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany

Maximilian Merz, MD
Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany

Gil Morgan, MD
Skåne University Hospital, Lund, Sweden

Alicia Morgans, MD
Genitourinary Medical Oncologist
Dana-Farber Cancer Institute, Boston, USA

Denis Moro-Sibilot, MD
Unité d’Oncologie Thoracique, Service Hospitalier Universitaire Pneumologie Physiologie Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Grenoble, France

Volkmar Müller, MD
Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Declan Murphy, MD
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne,
Australia

Paul Nathan, MD
Department of Medical Oncology, Mount Vernon Cancer Centre, London, UK

Andrea Necchi, MD
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Sumanta (Monty) Kumar Pal, MD
City of Hope National Medical Center, Duarte, CA, USA

Shani Paluch-Shimon, MD
Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel

Barbara Pistilli, MD
Breast Cancer Group, Gustave Roussy, Villejuif, France

Michael Postow, MD
Department of Medicine, Memorial Sloan Kettering Cancer Center New York, NY, USA

Tom Powles, MD
Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK

Martin Reck, MD
Lung Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany

Noemi Reguart, MD
Oncology Department, Hospital Clinic Barcelona, Spain

Sacha Rothschild, MD
Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, Basel, Switzerland

Hope Rugo, MD
Department of Medicine (Hematology/Oncology), Breast Oncology and Clinical Trials Education, University of California San Francisco, CA, USA

Dirk Schadendorf, MD
Department of Dermatology, University Hospital Essen, Germany

Fredrik Schjesvold, MD
Oslo Myeloma Center at Oslo University Hospital, Oslo, Norway

Andreas Schneeweiss, MD
Section gynecological oncology at the National Center for Tumor Diseases (Centrum für Tumorerkrankungen) (NCT) Heidelberg, Germany

Elzbieta Senkus-Konefka, MD
Department of Oncology & Radiotherapy, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland

Riyaz Shah, MD
Maidstone and Tunbridge Wells NHS Trust, Kent, UK

Neal Shore, MD
Carolina Urologic Research Center and Atlantic Urology Clinics, LLC, Myrtle Beach, South Carolina, USA

Pieter Sonneveld, MD
Erasmus MC Cancer Institute, Rotterdam, Netherlands

Daniel Shao-Weng Tan, MD
Division of Medical Oncology at National Cancer Centre Singapore; Duke-NUS Medical School, Singapore

Catherine Thieblemont, MD
Hemato-Oncology Department at Hôpital Saint-Louis, Paris, France

Michael Thomas, MD
Thorax Clinic Heidelberg, Heidelberg University Hospital, Heidelberg, Germany

Sara Tolaney, MD
Dana-Farber Cancer Institute, Harvard Medcial Scool, Boston, MA, USA

Michael Untch, MD
Department of Gynaecology and Obstetrics, Breast Cancer and Gynecologic Oncology Center, HELIOS Klinikum Berlin Buch, Germany

Katja Weisel, MD
Medizinische Klinik und Poliklinik, Zentrum für Onkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany